中国国家市场监管总局近日公布《药品经营和使用质量监督管理办法》，自 2024 年 1 月 1 日起施行。该办法旨在推动和促进医药行业转型升级，切实保障药品经营和使用环节质量安全。
作为一项关键的管理办法，该办法将加强对药品经营和使用全过程全环节监管，以确保医药行业的健康发展。办法规定，药品经营企业必须遵守经营规范，落实质量安全主体责任，建立完善的药品供应链和追溯体系，保证药品的质量和安全。
该办法的发布，对于推动医药行业转型升级、保障药品质量安全具有重要意义。它将促进医药行业向高质量、高效率的方向发展，提高医药行业的整体竞争力。
新闻翻译：
China’s State Administration of 市场监管总局 recently announced the “Measure for the Administration of Drug Sales and Use Quality”, which will take effect on January 1, 2024. The measure aims to promote and accelerate the transformation of the pharmaceutical industry, and ensure the safety and quality of drug sales and use processes.
As an essential administrative measure, the “Measure for the Administration of Drug Sales and Use Quality” will strengthen the supervision and control of drug sales and use throughout the entire process, ensuring the health and safety of drugs in the pharmaceutical industry. The measure requires drug trading enterprises to comply with business norms, bear the responsibility for quality safety, and establish a sound drug supply and traceback system to ensure the quality and safety of drugs.
The release of this measure is of great significance for promoting the transformation of the pharmaceutical industry and ensuring the safety and quality of drug sales and use. It will encourage the pharmaceutical industry to develop in the direction of high quality and high efficiency, and improve the overall competitiveness of the pharmaceutical industry.
【来源】http://www.chinanews.com/cj/2023/10-13/10093797.shtml
Views: 1